Back to Dashboard

DHN

Công ty Cổ phần Dược phẩm Hà Nội

VietnamConsumerY tếDược phẩmUPCOMCT
19.000
VND · Close 2 Nov 2026

Calibrated intrinsic value vs last close

Illustrative estimate
Comparison requires review
+16.8%Calibrated value vs last close
Last close (VND)
19.000
Calibrated intrinsic value (VND)
22.186

Last close × (1 + calibrated gap / 100)

Earnings-capitalised value

Not available: the company reported a loss last year or its shares have too short a price history.

How it is calculated

  1. 1
    Measure the gap

    Between the model and the last close.

  2. 2
    Check the record2015–2024

    What gaps of that size went on to earn over the following year.

  3. 3
    Apply to the close

    That return is applied to the last close.

Keep in mind

  • For illustration only: not a validated forecast.
  • No uncertainty range: the estimate is a single figure.
  • Older record: it has not been re-measured on the current data.

Why it needs review

  • Trading liquidity is below the comparison threshold.

Also note

  • Historical growth has declined.

This estimate remains visible for checking its calculation. Its inputs require review before using it in a stock comparison. The model comparison behind this value needs review. The estimate does not remove the data limitations listed above.

Model reliability
Low
Model fitInput stabilityRisk checks
High requires the model’s diagnostic criteria to be met.
Probability of outperforming peers
Not assessed
A separate peer-outperformance probability is unavailable for this valuation.
Assessed 30 Oct 2026Not updated with daily prices

These assessments address different questions. Neither establishes that the displayed valuation is correct or guarantees a future return.

Valuation Breakdown

CT→Y tế→Consumer
Classified as consumer because ICB sector “Y tế” maps to the consumer group.
ModelFCF-Based DCF
Intrinsic = 70% x DCF Value + 30% x (Fair P/E x EPS)

A Discounted Cash Flow model built on Free Cash Flow (FCF), the cash a business generates after operating expenses and capital expenditures. Future FCF is projected for 10 years with gradually decaying growth, then discounted to today's value using WACC. The DCF value is blended 70/30 with a value from the company's own historical P/E.

Technical details
Why this model

Consumer staples/retail generate steady, predictable free cash flows, making them ideal for DCF. The time value of money principle means a dollar today is worth more than a dollar tomorrow. DCF captures this by discounting future cash flows at a rate reflecting the investment's risk (WACC).

How it works

Takes 3-year median FCF as the base. Estimates growth via ROIC x reinvestment rate (Damodaran framework), falling back to historical revenue growth. Projects 10 years with decay toward the sector's long-run growth rate. Discounts at CAPM-derived WACC. Blends 70% of the DCF value with 30% of a P/E value: the company's 5-year median P/E, held between 5x and 25x, times EPS.

Best for

Stable consumer businesses (food, beverage, retail, healthcare) with predictable, positive free cash flows.

1
Weighted Avg Cost of Capital
Risk-Free (Rf)
4.36%
+
Betasector default
0.910
x
ERP
4.38%
+
CRP
2.75%
=
Cost of Equity (Ke)
11.10%
Ke
11.10%
x
E/(D+E)
100.00%
+
Kd(1-t)
0.00%
x
D/(D+E)
0.00%
=
WACC
11.10%
2
Growth Estimate
historical blend4.00%
Growth decays 10%/yr toward terminal
3
Model Inputs
Base FCF→16.80B
Projection years→10
4
Valuation

We take the model’s gap to the last close, read what gaps of that size went on to earn over the following year in our 2015 to 2024 record, and apply that to the last close.

Last close (VND)→19.000
Calibrated value vs last close→+16.8%

Last close × (1 + calibrated gap / 100)

Calibrated intrinsic value (VND)
22.186
What feeds each step— click a source to highlight it in the statements
Discount rate (WACC)11.10%
Growth rate4.00%growth method: historical blend
Base cash flow16.8 tỷone off strip ratio: 0

DCF Sensitivity

Illustrative calibrated values from the standalone DCF scenarios below, anchored to the same last close. These scenarios leave out the other parts of a blended model and do not reproduce the headline value.

WACC \ Growth1.0%2.5%4.0%5.5%7.0%
9.1%23.33023.33023.33023.33023.330
10.1%22.18622.18622.18623.00923.330
11.1%22.18622.18622.18622.18622.186
12.1%22.18622.18622.18622.18622.186
13.1%22.18622.18622.18622.18622.186
Above market priceBelow market priceCurrent estimate
Feeds valuation:Cost of capitalGrowthModel inputsFinal calculation
Line item2026202520242023202220212020201920182017201620152014
CURRENT ASSETS (Bn. VND)
·908679656963776655524853
Cash and cash equivalents (Bn. VND)Net debt bridge
·874016171561032282121
Short-term investments (Bn. VND)Net debt bridge
·63531325252325260000
Accounts receivable (Bn. VND)
·75112412413414
Prepayments to suppliers (Bn. VND)
·20.10.60.0310.30.200.90.08111
Net Inventories
·132125232520322521202217
Inventories, Net (Bn. VND)
·132125232520322524202217
Other current assets
·0.010.010.030.030.40.310.70.50.60.70.8
Other current assets (Bn. VND)
·0.0100000000000
LONG-TERM ASSETS (Bn. VND)
·171919232426303532323133
Fixed assets (Bn. VND)
·171919232426303532323133
Tangible fixed assets
·141616202123273128282729
Intagible fixed assets
·333333334444
TOTAL ASSETS (Bn. VND)
·1071059988938910710087847986
LIABILITIES (Bn. VND)
·13131671616352617141119
Current liabilities (Bn. VND)
·13131671616352617141119
Advances from customers (Bn. VND)
·0.40.50.60.90.411258210
OWNER'S EQUITY(Bn.VND)Discount rate (WACC)
·949283817773727470696867
Capital and reserves (Bn. VND)
·949283817773727470696867
Paid-in capital (Bn. VND)
·636363636363636363636363
Other Reserves
··3333333330.100.10
Investment and development funds (Bn. VND)
·32210.70.60.60.60.60.121
Other Reserves
·444444433333
Undistributed earnings (Bn. VND)
·2220121174240.20.60.50.6
TOTAL RESOURCES (Bn. VND)
·1071059988938910710087847986
Common shares (Bn. VND)
·636363636363636363636363

Earnings Quality

Fiscal year 2025
75
Good
Accrual Quality
100
Cash Conversion
100
Receivables
0
Margin Stability
90

Financial Forensics

Beneish M-Score · 2025
Remainder
M −2.55 · 36th pctile vs VN companies
YoY ▼ −3.91
Conservative vs VN peersUnusual accounting movement
Compare across the whole market

Ranked vs Vietnamese peers. The −1.78 Beneish cutoff is US-calibrated; ~28% of VN stocks exceed it.

DSRI
1.444
GMI
0.841
AQI
1.000
SGI
0.854
DEPI
1.000
SGAI
1.231
TATA
−0.048
LVGI
0.987

Checks measured on Vietnamese companies · FY2025

Cash conversion, 3 yearsOperating cash flow / net profit
1.1753rd pctile
Receivables outside the trade cyclePrepayments to suppliers, loans and other long-term receivables / total assets
1.7%45th pctile
Accumulated losses / paid-in capitalUndistributed earnings below zero
None
Consecutive years of net lossProfit after tax of the parent
0
Owner's equityWithout the non-controlling interest
Positive

Percentiles rank each fiscal year against Vietnamese non-financial companies (0 lowest, 100 highest). Over FY2015-2024, low cash conversion and a large share of receivables outside the trade cycle came before more listing trouble and more net losses the next year.

Statutory loss tests (Decree 155/2020/NĐ-CP, Art. 120(1)(e), amended by Decree 245/2025/NĐ-CP): a HOSE or HNX listing is cancelled when the audited annual statements show net losses in each of the latest 3 years, accumulated losses above the paid-in charter capital, or negative owner's equity. Read here from the annual statements as the data vendor publishes them. The company trades on UPCoM, where these tests do not apply.

Quantitative Scores

F-Score
6/9
Neutral
Z-Score
11.04
Safe Zone
Sharpe
−0.47
Negative
Composite
63
50 to 69
Piotroski F-Score Breakdown
✓Net Income > 0
✓Operating CF > 0
✗ROA Rising
✓OCF > Net Income
✗Lower Leverage
✓Better Liquidity
✓No Dilution
✓Margin Up
✗Turnover Up
DuPont Decomposition
Tax Burden0.79×Interest Burden1.00×Op. Margin0.28×Turnover0.68×Leverage1.14=ROE17.1%
Price Risk
Momentum
−37.6%
Volatility
66.5%
Max Drawdown
−49.4%

Key Ratios

Fiscal year 2025
7.12P/E
P/B
1.22
P/S
1.57
ROE
17.4%
ROA
15.3%
EPS
2.569
BVPS
14.979
Gross Margin
50.5%
Net Margin
22.1%
D/E
0.00
Current Ratio
6.96
EV/EBITDA
2.27
Div Yield
10.9%

Company Overview

Shares outstanding
6.3M
Charter Capital
62.9B VND
Sector (ICB L2)
Y tế
Industry (ICB L3)
Dược phẩm
Sub-industry
Dược phẩm
Company Type
CT
Computed 30/10/2026
Methodology & Disclosure

vnvalue is a stock research tool. Its results are calculated from public financial data with published formulas. Nothing on this page constitutes investment, financial, legal, or tax advice, nor a recommendation to buy, sell, or hold any security.

All data, models, and outputs are provided AS IS without warranty of any kind. You are solely responsible for your investment decisions. Past performance and historical valuations are not indicative of future results.

By using vnvalue you accept the Terms of Service and Privacy Policy. Full disclaimer →